ESC 365 - Additional use of SGLT2 inhibitors in the treatment of acute decompensated heart failure may prevent acute kidney injury

ESC Premium Access

Additional use of SGLT2 inhibitors in the treatment of acute decompensated heart failure may prevent acute kidney injury

Session: New aspects of heart failure treatment

Topic: Pharmacotherapy

Speaker: Doctor T. Kambara (Seto, JP)

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Doctor Takahiro Kambara

Nagoya University Graduate School of Medicine, Seto (Japan)

0 follower

6 more presentations in this session

Full combination of guideline-recommended medical therapy is associated with better long-term mortality in acute heart failure patients with low blood pressure and renal dysfunction

Speaker: Doctor M. Kametani (Tokyo, JP)

Impact of catheter ablation for atrial fibrillation on clinical outcome in elderly patients hospitalized for acute heart failure

Speaker: Doctor M. Manita (Naha, JP)

Cystatin C-based estimated glomerular filtration rate to predict diuretic response to tolvaptan in acute decompensated heart failure

Speaker: Doctor K. Tsuchida (Niigata, JP)

Heart failure specialist nurse-led day case ambulatory management with intravenous diuretics reduces hospitalisations for acute decompensated heart failure irrespective of ejection fraction

Speaker: Mrs S. Hassan (Liverpool, GB)

Comparison of changes in the plasma volume and renal function between acetazolamide vs. conventional diuretics: understanding their mechanical differences according to the chloride theory

Speaker: Doctor H. Kataoka (Saiki, JP)

Access the full session

New aspects of heart failure treatment

Speakers: Doctor T. Kambara, Doctor M. Kametani, Doctor M. Manita, Doctor K. Tsuchida, Mrs S. Hassan...

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources